Orelabrutinib Tablets Instructions for Use

Update: 29 October, 2023

Orelabrutinib Tablets are indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy and adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who have received at least one prior therapy.


File format: PDF

Size: -

MD5 Checksum: E8FD1FA4A7FFC6FF785697BE4597956F

Publication date: 29 October, 2023

Downloads: -

PDF Link: Orelabrutinib Tablets Instructions for Use PDF

Also Manuals